AKT2 and ovarian cancer: Notably, amplification of the 19q13.2 region in the ovarian cancer c6 subtype harboring the AKT2 gene is associated with poor survival (Additional file 1: Fig. S7f, Table S8) which was consistent with previous findings that AKT2 amplification is associated with ovarian cancer aggressiveness [30].